Proposal to Give FDA More Muscle Gets Mixed Reviews

May 11, 2007

A U.S. Senate bill that offers up the prospect of enhanced powers for the U.S. Food and Drug Administration in its dealings with the pharmaceutical industry is drawing both praise and criticism from health experts. (HealthDay)